Automated Cytomegalovirus PCR Assay Receives IVDR Certification for Transplant Care
The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.
The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.
Bio-Rad and Oncocyte are collaborating on transplant monitoring products using Bio-Rad’s Droplet Digital PCR instruments and reagents.Â
A University of Pittsburgh study not only identifies a warning signal that something is going wrong, but also suggests an existing medication that could be given to patients to aid their long-term recovery.
The Cobas Zika test detects Zika virus RNA in samples of human plasma and is intended for use in screening blood donations.
Read MoreDisqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read MoreDiscovery by Medical University of Vienna research team may lead to early identification of dangerous complications among transplant patients.
Read MoreAdoption of the technology is based on the premise that healthcare providers need to get the right bag of blood products to the right patient at the right time.
Read MoreWith an increasing US prevalence of vector-borne illnesses such as Lyme disease, there is a pressing need to improve clinical diagnostics.
Read MoreBD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read MoreAt FDA urging, Beckman Coulter has repeated its Class I recall letters for three hematology analyzers.
Read MoreRack Reader Traces 2D-Coded Tubes Synchronized reader and software Optimized for rapid and...
Read MoreThe system leverages innovative ultrasound technology to provide rapid viscoelastic results in 15 minutes or less.
Read MoreAssay enables screening for the presence of four clinically relevant species of the Babesia parasite in donated blood.
Read MoreAdoption of the new standards for laboratory connectivity has broad benefits for all stakeholders in the healthcare ecosystem.
Read MoreThe Erytra Eflexis analyzer performs pretransfusion compatibility testing, and can be used in combination with other Grifols blood typing solutions.
Read MoreThe molecular test is the first of its type approved to report genotypes as final results.
Read MoreBlood and test utilization management programs can improve patient care while reducing health system costs.
Read MoreThe molecular red blood cell typing test offers the shortest time to reportable results for US hospitals, reference labs, and blood centers.
Read More